Health Advisory: Influenza-Associated Neurological Complications and Influenza-Associated Deaths In Pediatric Populations
The Situation Report | March 10, 2025
The New York State Department of Health (NYSDOH), Bureau of Communicable Disease Control (BCDC) issued a health advisory to alert clinicians to national reports of severe neurological complications of influenza infection in children and of influenza-associated pediatric deaths in New York State during the 2024-2025 respiratory virus season.
- In late January 2025, the Centers for Disease Control and Prevention received anecdotal reports of children with influenza-associated acute necrotizing encephalopathy (ANE), a rare and severe form of influenza-associated encephalopathy or encephalitis (IAE), including several fatal cases
- Nationally, influenza-associated pediatric deaths are reportable, and preliminary data for the 2024– 25 season indicate that nine of 96 (9.3%) had influenza-associated encephalopathy.
- There is currently no national surveillance for influenza-associated encephalopathy or acute necrotizing encephalopathy, and it is not known whether reported cases are within or above expected ranges.
- Eighteen pediatric influenza-associated deaths have been reported to date in New York State during the 2024-2025 influenza Of these, 3 were ineligible for vaccination due to age, and the other 15 had no documentation of receipt of this season’s influenza vaccine. Evaluation is underway to determine whether there were signs of influenza-associated encephalopathy in these pediatric fatalities.
- In New York State, pediatric vaccination for seasonal influenza lags behind For the current season, only 30% of New York children eligible to receive the influenza vaccine are vaccinated.
Recommended Actions
- Health care providers are asked to monitor hospitalized pediatric patients with influenza for neurologic symptoms or neurologic abnormalities. These include:
- Diagnosis of encephalopathy or encephalitis
- Neurologic signs or symptoms including but not limited to seizures, altered mental status, delirium, decreased level of consciousness, lethargy, hallucinations, or personality changes lasting >24 hours
- Neuroimaging abnormalities including brain edema, brain inflammation, or brain lesions
- Electroencephalogram abnormalities
- Abnormal brain autopsy findings, if available, for children who died.
- Clinicians are encouraged to order respiratory virus testing in children presenting with new onset of neurological symptoms or neurologic abnormalities.
- Unless contraindicated, treat hospitalized pediatric patients with suspected seasonal influenza, especially those in an intensive care unit, with antiviral medication such as oseltamivir, without waiting for the results of influenza testing.
- Educate patients and parents of pediatric patients that vaccines provide protection against influenza, including reducing the likelihood of severe disease and death if infection does
- Promptly report pediatric patients with suspected influenza-associated encephalopathy and encephalitis, with or without acute necrotizing encephalopathy, to the NYSDOH Bureau of Communicable Disease Control at 518-473-4439 or at
This email address is being protected from spambots. You need JavaScript enabled to view it. or the NYC Department of Health and Mental Hygiene at 866-692-3641 for NYC residents. - Promptly report pediatric influenza-associated deaths to the local health department where the patient If the residence is in New York City, report to the New York City Department of Health and Mental Hygiene at 866-692-3641.
- Submit to Wadsworth Center all positive influenza samples from hospitalized patients requiring intensive care.
- Information regarding influenza specimen collection and shipping to Wadsworth Center can be found here.
- For questions about shipping on holidays or weekends, please call 518-474-
- Please ship specimens to:
David Axelrod Institute Virology Laboratory Wadsworth Center
New York State Department of Health 120 New Scotland Ave.
Albany, NY 12208